...strategics Eli Lilly & Co. (NYSE:LLY), PPD Inc. (NASDAQ:PPD...

...Xalu­­d Therapeutics Inc. hired Die­m Nguyen as CEO. Nguyen was EVP of biopharma at PPD Inc. (NASDAQ:PPD).AVM...

...major depressive disorder (MDD) and post-partum depression (PPD...

...III SKYLARK trial, to treat postpartum depression (PPD).The...
...and the Phase III ROBIN study in PPD...

...series C round led by Sapphire Ventures, with participation from existing investors GSR Ventures, PPD Inc. (NASDAQ:PPD...

...indication. Both readouts led to sharp declines in Marinus’ share price (see “Marinus Plummets After PPD...

...in a series D1 round led by existing investors Lux Capital, Redmile Group and PPD Inc. (NASDAQ:PPD...

...$1.9 billion offering by contract researcher PPD Inc., which had a postmoney valuation of $9 billion (NASDAQ:PPD...

...Inc. Lyra Therapeutics Inc. ORIC Pharmaceuticals Inc. Keros Therapeutics Inc. Zentalis Pharmaceuticals Inc. Imara Inc. Passage Bio Inc. Revolution Medicines Inc. Beam Therapeutics Inc. PPD Inc. Schroedinger...

...raised to more than $45 million. GSR Ventures led the round with participation from PPD Inc. (NASDAQ:PPD...